Senna — Class II drug recall D-1437-2019
Terminated recall by Geritrex, LLC, reported 2019-06-19, distributed nationwide. Failed Impurities/Degradation Specifications: Atypical odor and unpleasant taste was reported
| Recall number | D-1437-2019 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Geritrex, LLC, Middletown, NY, United States |
| Recall initiated | 2019-05-06 |
| Classified | 2019-06-28 |
| Reported by FDA | 2019-06-19 |
| Terminated | 2024-02-21 |
| Distributed | Nationwide (US) |
| Quantity | 24,312 units |
| Reason classes | specification failure |
| NDC | 54162-0007-08 |
| Lot numbers | 1806014, 1806031 |
| Expiration dates | 2019-08 |
Product
Senna (sennosides 8.8 mg) Syrup 8 fl oz. (236 mL) bottles, Distributed by Geritrex, LLC 40 Commercial Avenue Middletown, NY 10941, NDC 54162-007-08
Reason for recall
Failed Impurities/Degradation Specifications: Atypical odor and unpleasant taste was reported
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1437-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.